Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Amy Franks

Concepts (190)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Education, Pharmacy
18
2024
146
8.370
Why?
Schools, Pharmacy
8
2024
53
3.580
Why?
Pharmacy
3
2023
54
2.070
Why?
Writing
4
2024
44
1.770
Why?
Students, Pharmacy
5
2024
124
1.690
Why?
Faculty
7
2024
72
1.260
Why?
Professional-Patient Relations
3
2019
48
1.250
Why?
Teaching
4
2024
113
1.080
Why?
Educational Measurement
6
2019
206
0.990
Why?
Career Choice
1
2024
112
0.860
Why?
Pharmaceutical Services
2
2023
52
0.850
Why?
Students
3
2024
223
0.850
Why?
Learning
2
2024
159
0.810
Why?
Fellowships and Scholarships
2
2020
120
0.800
Why?
Humans
43
2024
50503
0.790
Why?
Pharmacies
1
2023
60
0.780
Why?
Biomedical Research
1
2024
244
0.750
Why?
Patient-Centered Care
2
2019
130
0.680
Why?
Motivational Interviewing
2
2019
32
0.670
Why?
Health Knowledge, Attitudes, Practice
4
2018
491
0.650
Why?
Program Development
2
2018
162
0.590
Why?
Blood Pressure
3
2012
531
0.580
Why?
Probucol
2
2009
3
0.580
Why?
Mass Screening
2
2011
344
0.570
Why?
Achievement
1
2017
39
0.560
Why?
Patient Education as Topic
2
2011
320
0.560
Why?
Perception
1
2017
116
0.540
Why?
Cross-Sectional Studies
7
2020
1610
0.510
Why?
Feedback
1
2016
53
0.510
Why?
Tetrazoles
2
2008
41
0.500
Why?
Antihypertensive Agents
2
2009
125
0.500
Why?
Hypertension
3
2009
544
0.480
Why?
Health Personnel
1
2017
247
0.460
Why?
Research Personnel
2
2024
65
0.430
Why?
Curriculum
5
2019
400
0.400
Why?
Community Health Services
2
2011
101
0.400
Why?
Energy Drinks
1
2012
6
0.390
Why?
Female
17
2024
27081
0.390
Why?
Caffeine
1
2012
64
0.380
Why?
Platelet Aggregation Inhibitors
2
2012
174
0.370
Why?
Faculty, Medical
2
2023
92
0.370
Why?
Coronary Disease
1
2011
152
0.350
Why?
Universities
2
2024
171
0.350
Why?
Cardiovascular Diseases
3
2012
461
0.350
Why?
Male
15
2024
25907
0.340
Why?
Adrenergic beta-Antagonists
1
2009
108
0.320
Why?
Cardiovascular System
1
2009
52
0.310
Why?
Biphenyl Compounds
1
2008
31
0.310
Why?
Angiotensin II Type 1 Receptor Blockers
1
2008
43
0.300
Why?
Benzimidazoles
1
2008
48
0.300
Why?
Thiazolidinediones
1
2007
82
0.270
Why?
Adult
11
2024
13577
0.260
Why?
Coronary Restenosis
1
2005
31
0.250
Why?
Hypoglycemic Agents
1
2007
173
0.250
Why?
Clinical Trials as Topic
4
2009
486
0.230
Why?
Program Evaluation
2
2024
349
0.220
Why?
Smoking
2
2018
507
0.220
Why?
Policy
1
2023
24
0.220
Why?
Career Mobility
1
2023
28
0.220
Why?
Organizational Policy
1
2023
39
0.210
Why?
Academies and Institutes
1
2023
17
0.210
Why?
Communication
2
2022
250
0.210
Why?
Checklist
1
2023
29
0.210
Why?
Angiotensin Receptor Antagonists
1
2003
18
0.210
Why?
Imidazoles
1
2003
127
0.190
Why?
Schools
1
2023
164
0.190
Why?
Angiotensin II
1
2003
160
0.190
Why?
Heart Failure
1
2007
528
0.190
Why?
Itraconazole
3
2008
35
0.180
Why?
Diabetes Mellitus, Type 2
1
2007
519
0.180
Why?
Amiodarone
1
2000
22
0.180
Why?
Qualitative Research
1
2023
349
0.180
Why?
Cannabis
1
2023
146
0.180
Why?
Anti-Arrhythmia Agents
1
2000
80
0.170
Why?
Mentors
1
2020
55
0.170
Why?
Blood Pressure Monitoring, Ambulatory
2
2012
36
0.170
Why?
Heart Arrest
2
2007
155
0.170
Why?
Self Report
1
2020
206
0.150
Why?
Peer Review
1
2018
9
0.150
Why?
Self-Assessment
2
2016
43
0.150
Why?
Pilot Projects
3
2009
698
0.150
Why?
Motivation
1
2020
275
0.150
Why?
Publishing
1
2018
40
0.150
Why?
Risk Factors
4
2011
3724
0.140
Why?
Knowledge
1
2017
28
0.140
Why?
Citrus paradisi
2
2008
10
0.130
Why?
Food-Drug Interactions
2
2008
14
0.130
Why?
Education, Pharmacy, Graduate
1
2016
19
0.130
Why?
Tobacco Products
1
2018
126
0.130
Why?
Pharmacists
3
2023
145
0.120
Why?
Arkansas
3
2023
1985
0.120
Why?
Middle Aged
7
2023
12611
0.110
Why?
Young Adult
3
2018
4102
0.110
Why?
Antifungal Agents
2
2008
331
0.110
Why?
Retrospective Studies
2
2024
6263
0.110
Why?
United States
2
2021
4955
0.100
Why?
Dose-Response Relationship, Drug
2
2008
1372
0.100
Why?
Ticlopidine
1
2012
53
0.100
Why?
Proton Pump Inhibitors
1
2012
83
0.100
Why?
Life Style
1
2011
144
0.090
Why?
Drug Interactions
3
2012
206
0.090
Why?
Atenolol
1
2009
13
0.080
Why?
Cerebrovascular Disorders
1
2009
53
0.080
Why?
Health Behavior
1
2011
253
0.080
Why?
Drug Tolerance
1
2009
60
0.080
Why?
Drug Evaluation, Preclinical
1
2009
145
0.080
Why?
Beverages
2
2008
56
0.070
Why?
Problem-Based Learning
1
2008
49
0.070
Why?
Hirudins
1
2007
16
0.070
Why?
Education, Medical, Undergraduate
1
2008
86
0.070
Why?
Anaphylaxis
1
2007
69
0.070
Why?
Edema
1
2007
69
0.070
Why?
Drugs, Investigational
1
2005
14
0.060
Why?
Students, Medical
1
2008
162
0.060
Why?
Weight Gain
1
2007
237
0.060
Why?
Insulin Resistance
1
2007
268
0.060
Why?
Molecular Structure
1
2005
296
0.060
Why?
Insulin
1
2007
467
0.060
Why?
Risk Assessment
1
2009
1270
0.060
Why?
Anticoagulants
1
2007
256
0.060
Why?
beta-Cyclodextrins
1
2004
16
0.060
Why?
Tachycardia, Ventricular
2
2003
44
0.060
Why?
Antioxidants
1
2005
239
0.050
Why?
Ephedra
1
2003
8
0.050
Why?
Electrocardiography, Ambulatory
1
2003
23
0.050
Why?
Phytotherapy
1
2003
45
0.050
Why?
Plant Preparations
1
2003
39
0.050
Why?
Receptors, Angiotensin
1
2003
12
0.050
Why?
Prescription Fees
1
2003
14
0.050
Why?
Hemostasis
1
2003
59
0.050
Why?
Adolescent
2
2018
6443
0.050
Why?
Animals
2
2009
13124
0.050
Why?
Practice Guidelines as Topic
2
2007
468
0.050
Why?
Hepatocytes
1
2003
178
0.050
Why?
Aged, 80 and over
1
2009
3226
0.050
Why?
Interleukin-6
1
2003
261
0.050
Why?
Ventricular Fibrillation
1
2000
16
0.050
Why?
Attitude of Health Personnel
1
2023
352
0.040
Why?
Attitude
1
2019
69
0.040
Why?
Dietary Supplements
1
2003
449
0.040
Why?
Aged
2
2012
9741
0.040
Why?
Cardiopulmonary Resuscitation
1
2000
139
0.040
Why?
Pregnant Women
1
2018
72
0.030
Why?
Risk
1
2018
324
0.030
Why?
Liver
1
2003
1132
0.030
Why?
Nicotine
1
2018
184
0.030
Why?
Attitude to Health
1
2018
193
0.030
Why?
Societies, Pharmaceutical
1
2016
12
0.030
Why?
Pandemics
1
2021
563
0.030
Why?
Pharmaceutical Solutions
2
2008
8
0.030
Why?
Accreditation
1
2016
61
0.030
Why?
Child
1
2008
6906
0.030
Why?
Area Under Curve
2
2008
179
0.030
Why?
Cross-Over Studies
2
2008
228
0.030
Why?
Time Factors
2
2012
2935
0.020
Why?
Regression Analysis
1
2012
382
0.020
Why?
Acute Coronary Syndrome
1
2012
76
0.020
Why?
Proportional Hazards Models
1
2012
415
0.020
Why?
Pregnancy
1
2018
2452
0.020
Why?
Cohort Studies
1
2012
1452
0.020
Why?
Peer Group
1
2008
56
0.020
Why?
Hospitalization
1
2012
675
0.020
Why?
Cytochrome P-450 CYP3A
1
2008
77
0.020
Why?
Risk Management
1
2007
32
0.020
Why?
Injections, Intravenous
1
2007
137
0.020
Why?
Follow-Up Studies
1
2012
2242
0.020
Why?
Antibodies
1
2007
153
0.020
Why?
Administration, Oral
1
2008
434
0.020
Why?
Renal Insufficiency
1
2007
110
0.020
Why?
Respiratory Insufficiency
1
2007
117
0.020
Why?
Recombinant Proteins
1
2007
476
0.020
Why?
Sex Factors
1
2008
712
0.020
Why?
Clinical Competence
1
2008
398
0.020
Why?
Cyclodextrins
1
2004
18
0.010
Why?
Biological Availability
1
2004
102
0.010
Why?
Ephedrine
1
2003
21
0.010
Why?
Cimetidine
1
2003
7
0.010
Why?
Receptors, Interleukin-6
1
2003
22
0.010
Why?
Diastole
1
2003
70
0.010
Why?
Bradycardia
1
2003
37
0.010
Why?
Systole
1
2003
72
0.010
Why?
Reference Values
1
2003
307
0.010
Why?
Cytochrome P-450 Enzyme System
1
2003
194
0.010
Why?
Patient Compliance
1
2003
233
0.010
Why?
Heart Rate
1
2003
307
0.010
Why?
Body Weight
1
2003
517
0.010
Why?
Enzyme Inhibitors
1
2003
377
0.010
Why?
Body Mass Index
1
2003
677
0.010
Why?
Cells, Cultured
1
2003
1571
0.010
Why?
Treatment Outcome
1
2003
5283
0.010
Why?
Franks's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description